These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 38331250
1. Correlation between pre-radical prostatectomy standardized SUVmax ratios detected on 68Ga-PSMA-I&T PET/CT and final histopathology outcomes: an in-depth analysis. Arıkan MG, Soyluoğlu S, Korkmaz Ü, Taştekin E, Elboğa U, Arda E. Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):100-106. PubMed ID: 38331250 [Abstract] [Full Text] [Related]
2. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters. Mazzone E, Gandaglia G, Robesti D, Rajwa P, Gomez Rivas J, Ibáñez L, Soeterik TFW, Bianchi L, Afferi L, Kesch C, Darr C, Guo H, Zhuang J, Zattoni F, Fendler WP, Amparore D, Huebner NA, Giesen A, Joniau S, Schiavina R, Brunocilla E, Mattei A, Dal Moro F, Moreno Sierra J, Porpiglia F, Picchio M, Chiti A, van den Bergh R, Shariat SF, Montorsi F, Briganti A. Eur Urol Oncol; 2024 Apr; 7(2):231-240. PubMed ID: 37689506 [Abstract] [Full Text] [Related]
3. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values. Rogic I, Golubic AT, Zuvic M, Smitran T, Jukic N, Gamulin M, Kastelan Z, Huic D. Nucl Med Rev Cent East Eur; 2024 Apr; 27(0):6-12. PubMed ID: 38680016 [Abstract] [Full Text] [Related]
4. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study. Ucar T, Gunduz N, Demirci E, Culpan M, Gunel H, Kir G, Atis RG, Yildirim A. Prostate; 2022 Nov; 82(15):1462-1468. PubMed ID: 35915579 [Abstract] [Full Text] [Related]
5. Direct Patlak Reconstruction of [68Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study. Rasul S, Geist BK, Einspieler H, Fajkovic H, Shariat SF, Schmitl S, Mitterhauser M, Bartosch R, Langsteger W, Baltzer PAT, Beyer T, Ferrara D, Haug AR, Hacker M, Rausch I. Int J Mol Sci; 2023 Sep 05; 24(18):. PubMed ID: 37761975 [Abstract] [Full Text] [Related]
6. The Relationship between D'Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers. Ulas Babacan O, Hasbek Z, Seker K. Curr Oncol; 2024 Sep 08; 31(9):5307-5317. PubMed ID: 39330019 [Abstract] [Full Text] [Related]
7. Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit. Maestroni UV, Campobasso D, Guarino G, Acampora A, Scarlattei M, Ziglioli F, Dinale F, Baldari G, Migliari S, Gasparro D, Ferretti S, Silini EM, Ruffini L. Chin Clin Oncol; 2023 Jun 08; 12(3):22. PubMed ID: 37417288 [Abstract] [Full Text] [Related]
8. The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy. Gultekin MH, Demirci E, Turegun FA, Kabasakal L, Sahin OE, Ocak M, Onal B, Erozenci A. Urol J; 2020 Dec 09; 18(1):58-65. PubMed ID: 33349912 [Abstract] [Full Text] [Related]
9. Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer. Bodar YJL, Veerman H, Meijer D, de Bie K, van Leeuwen PJ, Donswijk ML, van Moorselaar RJA, Hendrikse NH, Boellaard R, Oprea-Lager DE, Vis AN. BJU Int; 2022 Jun 09; 129(6):768-776. PubMed ID: 35166426 [Abstract] [Full Text] [Related]
10. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer. Franklin A, Yaxley WJ, Raveenthiran S, Coughlin G, Gianduzzo T, Kua B, McEwan L, Wong D, Delahunt B, Egevad L, Samaratunga H, Brown N, Parkinson R, Roberts MJ, Yaxley JW. BJU Int; 2021 Jan 09; 127(1):71-79. PubMed ID: 32524748 [Abstract] [Full Text] [Related]
11. The additional value of 68Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy. Heetman JG, Paulino Pereira LJ, Kelder JC, Soeterik TFW, Wever L, Lavalaye J, van der Hoeven EJRJ, Lam MGEH, van Melick HHE, van den Bergh RCN. Prostate; 2024 Aug 09; 84(11):1025-1032. PubMed ID: 38704755 [Abstract] [Full Text] [Related]
12. The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer. Esen B, Seymen H, Gurses B, Armutlu A, Koseoglu E, Tarim K, Ertoy Baydar D, Sarikaya AF, Canda AE, Balbay D, Kordan Y, Tilki D, Esen T, Demirkol MO. Prostate; 2024 Jan 09; 84(1):32-38. PubMed ID: 37661579 [Abstract] [Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 Jan 09; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
14. Correlations of 68Ga-PSMA PET/CT in the initial staging of prostate cancer patients. Topuz ÖV, Aksu A, Erinç SR, Tamam MÖ. Hell J Nucl Med; 2021 Jan 09; 24(1):60-65. PubMed ID: 33866340 [Abstract] [Full Text] [Related]
15. 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer. Klingenberg S, Jochumsen MR, Ulhøi BP, Fredsøe J, Sørensen KD, Borre M, Bouchelouche K. J Nucl Med; 2021 Feb 09; 62(2):214-220. PubMed ID: 32444374 [Abstract] [Full Text] [Related]
16. How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses. Erdem S, Simsek DH, Degirmenci E, Aydin R, Bagbudar S, Ozluk Y, Sanli Y, Sanli O, Ozcan F. Urol Oncol; 2022 Jan 09; 40(1):6.e1-6.e9. PubMed ID: 34400066 [Abstract] [Full Text] [Related]
17. Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI. Scheltema MJ, Chang JI, Stricker PD, van Leeuwen PJ, Nguyen QA, Ho B, Delprado W, Lee J, Thompson JE, Cusick T, Spriensma AS, Siriwardana AR, Yuen C, Kooner R, Hruby G, O'Neill G, Emmett L. BJU Int; 2019 Nov 09; 124 Suppl 1():42-49. PubMed ID: 31287613 [Abstract] [Full Text] [Related]
18. Is there a nonnegligible effect of maximum standardized uptake value in the staging and management of prostate cancer with 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography imaging? A single-center experience. Ekmekcioglu O, Yavuzsan AH, Arican P, Kirecci SL. J Cancer Res Ther; 2021 Nov 09; 17(6):1351-1357. PubMed ID: 34916365 [Abstract] [Full Text] [Related]
19. Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study. Schollhammer R, Robert G, Asselineau J, Yacoub M, Vimont D, Balamoutoff N, Bladou F, Bénard A, Hindié E, Gallerande HC, Morgat C. J Nucl Med; 2023 Mar 09; 64(3):379-385. PubMed ID: 36215569 [Abstract] [Full Text] [Related]
20. 68Ga-PSMA PET/CT: Does it predict adverse pathology findings at radical prostatectomy? Dekalo S, Kuten J, Mabjeesh NJ, Beri A, Even-Sapir E, Yossepowitch O. Urol Oncol; 2019 Sep 09; 37(9):574.e19-574.e24. PubMed ID: 31204017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]